Cargando…

The effects of testosterone replacement therapy on the prostate: a clinical perspective

Male hypogonadism is a clinical syndrome characterized by low testosterone and symptoms of androgen deficiency. Prostate cancer remains a significant health burden and cause of male mortality worldwide. The use of testosterone replacement therapy drugs is rising year-on-year for the treatment of and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miah, Saiful, Tharakan, Tharu, Gallagher, Kylie A, Shah, Taimur T, Winkler, Mathias, Jayasena, Channa N, Ahmed, Hashim U, Minhas, Suks
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392157/ https://www.ncbi.nlm.nih.gov/pubmed/30828436 http://dx.doi.org/10.12688/f1000research.16497.1

Ejemplares similares

Investigating the basis of sexual dysfunction during late-onset hypogonadism
por: Tharakan, Tharu, et al.
Publicado: (2019)

Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic–androgenic steroids (AAS)
por: Desai, Ankit, et al.
Publicado: (2022)

Non-obstructive azoospermia: current and future perspectives
por: Tharakan, Tharu, et al.
Publicado: (2021)

Are sex disparities in COVID-19 a predictable outcome of failing men’s health provision?
por: Tharakan, Tharu, et al.
Publicado: (2021)

Does hormonal therapy improve sperm retrieval rates in men with non-obstructive azoospermia: a systematic review and meta-analysis
por: Tharakan, Tharu, et al.
Publicado: (2022)

Prostate imaging and focal therapy
por: Connor, Martin J., et al.
Publicado: (2020)

A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer
por: Khoo, Christopher C., et al.
Publicado: (2020)

A review of recent evidence on androgen abuse from interviews with users
por: Grant, Bonnie, et al.
Publicado: (2023)

The role of seminal reactive oxygen species assessment in the setting of infertility and early pregnancy loss
por: Davies, Rhianna, et al.
Publicado: (2023)

Prostate imaging features that indicate benign or malignant pathology on biopsy
por: Lovegrove, Catherine Elizabeth, et al.
Publicado: (2018)

The Role of Seminal Oxidative Stress in Recurrent Pregnancy Loss
por: Davies, Rhianna, et al.
Publicado: (2023)

Kisspeptin and Testicular Function—Is It Necessary?
por: Sharma, Aditi, et al.
Publicado: (2020)

A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach
por: Miah, Saiful, et al.
Publicado: (2019)

Recent advances in understanding and managing Lichen Sclerosus
por: Kwok, Rachel, et al.
Publicado: (2020)

Penile implant surgery-managing complications
por: Cayetano-Alcaraz, Axel Alberto, et al.
Publicado: (2021)

Survey of endocrinologists managing recovery from anabolic androgenic steroid induced hypogonadism
por: Grant, Bonnie, et al.
Publicado: (2023)

Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy
por: Connor, Martin J., et al.
Publicado: (2020)

Endocrine‐disrupting chemicals and male reproductive health
por: Sharma, Aditi, et al.
Publicado: (2020)

Animal Models of Diabetes-Related Male Hypogonadism
por: Dimakopoulou, Anastasia, et al.
Publicado: (2019)

Testosterone Replacement Therapy in the Aged Male: Monitoring Patients’ Quality of Life Utilizing Scoring Systems
por: Tsampoukas, Georgios, et al.
Publicado: (2022)

Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012)

Approach to the Patient: The Evaluation and Management of Men ≥50 Years With Low Serum Testosterone Concentration
por: Grossmann, Mathis, et al.
Publicado: (2023)

Current techniques of prostate biopsy: an update from past to present
por: Noureldin, Mohamed Essam, et al.
Publicado: (2020)

The death of ink: the value of typing skills as an addition to the medical school curriculum
por: Miah, Saiful, et al.
Publicado: (2017)

Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
por: Atan, Ali, et al.
Publicado: (2013)

Testosterone Replacement Therapy and Prostate Cancer Incidence
por: Eisenberg, Michael Louis
Publicado: (2015)

Testosterone replacement therapy and the risk of prostate cancer
por: Warburton, Daniel, et al.
Publicado: (2015)

Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
por: Bell, Michael A., et al.
Publicado: (2018)

Alternatives to testosterone replacement: testosterone restoration
por: McCullough, Andrew
Publicado: (2015)

“Prostate telocytes change their phenotype in response to castration or testosterone replacement”
por: Felisbino, Sérgio Luis, et al.
Publicado: (2019)

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
por: Loeb, Stacy, et al.
Publicado: (2017)

BPH and prostate cancer risk
por: Miah, Saiful, et al.
Publicado: (2014)

AB004. Contemporary perspectives on testosterone replacement therapy (TRT)
por: Hellstrom, Wayne J. G.
Publicado: (2015)

Testosterone replacement therapy
por: Shoskes, Daniel A., et al.
Publicado: (2016)

Testosterone Replacement Therapy
por: Hellstrom, Wayne J.G.
Publicado: (2004)

Kyzatrex - Oral testosterone replacement therapy
por: Asghar, Adam Ali, et al.
Publicado: (2022)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Is Oral Testosterone the New Frontier of Testosterone Replacement Therapy?
por: Ahmad, Syed W, et al.
Publicado: (2022)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015)

Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
por: Kim, Jin Wook
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3s2vstp5v3d448nmhj0eha5ois